These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16955468)
1. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma. Chng WJ; Ketterling RP; Fonseca R Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468 [TBL] [Abstract][Full Text] [Related]
2. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology? Jimenez-Zepeda VH; Neme-Yunes Y; Braggio E Eur J Haematol; 2011 Jul; 87(1):20-7. PubMed ID: 21692850 [TBL] [Abstract][Full Text] [Related]
3. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686 [TBL] [Abstract][Full Text] [Related]
4. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution. Jimenez-Zepeda VH; Braggio E; Fonseca R Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591 [TBL] [Abstract][Full Text] [Related]
5. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases. Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697 [TBL] [Abstract][Full Text] [Related]
6. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834 [TBL] [Abstract][Full Text] [Related]
7. Cytogenetics and molecular cytogenetics in multiple myeloma. Liebisch P; Döhner H Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866 [TBL] [Abstract][Full Text] [Related]
8. Chromosome 1 abnormalities in multiple myeloma. Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492 [TBL] [Abstract][Full Text] [Related]
9. Chromosomes in plasma-cell malignancies. Van Den Berghe H Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595 [TBL] [Abstract][Full Text] [Related]
10. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination. Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995 [TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Schmidt-Wolf IG; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G Cancer Genet Cytogenet; 2006 May; 167(1):20-5. PubMed ID: 16682281 [TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of multiple myeloma. Tonon G Hematol Oncol Clin North Am; 2007 Dec; 21(6):985-1006, vii. PubMed ID: 17996585 [TBL] [Abstract][Full Text] [Related]
13. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343 [TBL] [Abstract][Full Text] [Related]
15. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients. Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M; Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464 [TBL] [Abstract][Full Text] [Related]
16. Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics. Cremer FW; Bila J; Buck I; Kartal M; Hose D; Ittrich C; Benner A; Raab MS; Theil AC; Moos M; Goldschmidt H; Bartram CR; Jauch A Genes Chromosomes Cancer; 2005 Oct; 44(2):194-203. PubMed ID: 16001433 [TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients. Smetana J; Fröhlich J; Vranová V; Mikulásová A; Kuglik P; Hájek R Klin Onkol; 2011; 24 Suppl():S43-8. PubMed ID: 21923064 [TBL] [Abstract][Full Text] [Related]
18. A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer. Nestor AL; Hollopeter SL; Matsui SI; Allison D Cytogenet Genome Res; 2007; 116(4):235-47. PubMed ID: 17431320 [TBL] [Abstract][Full Text] [Related]
19. Genetics of multiple myeloma. Higgins MJ; Fonseca R Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735 [TBL] [Abstract][Full Text] [Related]
20. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]